We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil’s ANVISA Expedites Approvals for COVID-19 Products
Brazil’s ANVISA Expedites Approvals for COVID-19 Products
Brazil’s National Health Surveillance Agency (ANVISA) is expediting approvals for medical devices and in vitro diagnostics related to the COVID-19 pandemic.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor